Jove
Visualize
Contact Us

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Vaccinations01:51

Vaccinations

53.9K
Overview
53.9K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

15.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing high cervical cancer rates in the Rio Grande Valley along the Texas-Mexico border: a community-based initiative focused on education, patient navigation, and medical provider training/telementoring.

Perspectives in public health·2021
Same author

[Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction].

Annales de cardiologie et d'angeiologie·2020
Same author

Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.

Diabetes & metabolism·2019
Same author

Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.

Preventive medicine·2018
Same author

Differences in the kinematics of booster-seated pediatric occupants using two different car seats.

Traffic injury prevention·2017
Same author

Prophylactic HPV vaccination: past, present, and future - CORRIGENDUM.

Epidemiology and infection·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 1, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Prophylactic HPV vaccination: past, present, and future.

P E Castle1, M Maza2

  • 1Department of Epidemiology and Population Health,Albert Einstein College of Medicine,Bronx,NY,USA.

Epidemiology and Infection
|October 3, 2015
PubMed
Summary

Human papillomavirus (HPV) vaccination is crucial for preventing cervical and other cancers. Vaccines are safe and effective, especially for young females, making universal HPV immunization a global health priority.

Keywords:
Human papillomavirus (HPV)vaccine-preventable diseasesvaccinesvirology (human) and epidemiology

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Related Experiment Videos

Last Updated: Apr 1, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Area of Science:

  • Oncology
  • Virology
  • Public Health

Background:

  • Human papillomavirus (HPV) is the primary cause of cervical cancer, a leading cancer-related death in females globally.
  • HPV also contributes to other cancers, including anal, vulvar, penile, and oropharyngeal cancers.
  • Prophylactic HPV vaccines, utilizing virus-like particles, have been developed to prevent HPV infections and related diseases.

Purpose of the Study:

  • To review the efficacy, safety, and cost-effectiveness of available prophylactic HPV vaccines.
  • To emphasize the importance of universal HPV vaccination as a global health priority.

Main Methods:

  • Review of clinical trial data on HPV vaccine efficacy and safety in adolescent and adult populations.
  • Analysis of population-level data on HPV genotype prevalence and disease reduction in countries with established vaccination programs.
  • Assessment of cost-effectiveness data, particularly for HPV-naive young females.

Main Results:

  • First-generation HPV vaccines target HPV16/18 (70% of cervical cancer) and some include HPV6/11 (90% of genital warts).
  • Next-generation vaccines cover approximately 90% of cervical cancer-causing HPV types plus HPV6/11.
  • Vaccines demonstrate high efficacy in clinical trials, with excellent safety profiles after over 100 million doses worldwide.
  • Population-level data show decreased HPV prevalence and related diseases in vaccinated cohorts and herd protection in males.
  • Cost-effectiveness is highest when administered to HPV-naive young females before sexual activity.

Conclusions:

  • HPV vaccination is highly effective, safe, and cost-effective, particularly for young females prior to sexual debut.
  • Universal HPV vaccination for adolescent females and high-risk males should be a global health priority to reduce the burden of HPV-related cancers.
  • Failure to prioritize HPV vaccination will result in millions of preventable deaths from cervical and other HPV-associated cancers, especially in low- and middle-income countries.